YALDIGO cpr 1600 mg 90 pce
7680531080035
CH-53108
A07EC02
04.09.0.
1 / 3
google
Details
- Product number
- 5310803
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- mesalazinum 1600 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 2.268 mg, hypromellosum, silica colloidalis, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, kalii dihydrogenophosphas, maydis amylum, E 172, pro compresso obducto.
Articles (1)
Yaldigo 1600 mg, magensaftresistente Tablette
Tablette
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.268 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Authorization holder
Tillotts Pharma AG
4310 Rheinfelden
Authorization information
- Swissmedic authorization number
- 53108
- Drug name
- Yaldigo, magensaftresistente Tablette
- Galenic form
- FILM
- ATC Code
- A07EC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/11/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 04.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- YALDIGO cpr 1600 mg 90 pce
- Description (DE)
- YALDIGO Tabl 1600 mg 90 Stk
- Market launch
- 17/07/2019
- Narcotic (BTM)
- No